By expenditures
| Name | Title | Type |
|---|---|---|
| Patty Sanchez | Administrative Director | Auditee |
| Melissa Elwood | Executive Director | Auditee |
| Bobby J. Patel | Partner | Auditee |
| Andrew Park | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 376178 | 2025 | 2025-12-18 | EIDE BAILLY LLP | $42.71M |
| 337991 | 2024 | 2025-01-15 | Eide Bailly LLP | $46.13M |
| 296464 | 2023 | 2024-03-21 | Eide Bailly LLP | $71.87M |
| 35218 | 2022 | 2023-04-11 | Eide Bailly LLP | $116.06M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 337991 | 2024 | 2025-01-15 | 1095723 | 2024-002 | Significant Deficiency | - | N |
| 337991 | 2024 | 2025-01-15 | 1095722 | 2024-002 | Significant Deficiency | - | N |
| 337991 | 2024 | 2025-01-15 | 519281 | 2024-002 | Significant Deficiency | - | N |
| 337991 | 2024 | 2025-01-15 | 519280 | 2024-002 | Significant Deficiency | - | N |
| 296464 | 2023 | 2024-03-21 | 959343 | 2023-003 | Significant Deficiency | - | AB |
| 296464 | 2023 | 2024-03-21 | 959342 | 2023-003 | Significant Deficiency | - | AB |
| 296464 | 2023 | 2024-03-21 | 959341 | 2023-003 | Significant Deficiency | - | AB |
| 296464 | 2023 | 2024-03-21 | 959340 | 2023-003 | Significant Deficiency | - | AB |
| 296464 | 2023 | 2024-03-21 | 959339 | 2023-003 | Significant Deficiency | - | AB |
| 296464 | 2023 | 2024-03-21 | 959338 | 2023-003 | Significant Deficiency | - | AB |
| 296464 | 2023 | 2024-03-21 | 959337 | 2023-002 | Significant Deficiency | - | N |
| 296464 | 2023 | 2024-03-21 | 959336 | 2023-002 | Significant Deficiency | - | N |
| 296464 | 2023 | 2024-03-21 | 959335 | 2023-002 | Significant Deficiency | - | N |
| 296464 | 2023 | 2024-03-21 | 959334 | 2023-002 | Significant Deficiency | - | N |
| 296464 | 2023 | 2024-03-21 | 959333 | 2023-002 | Significant Deficiency | - | N |
| 296464 | 2023 | 2024-03-21 | 959332 | 2023-002 | Significant Deficiency | - | N |
| 296464 | 2023 | 2024-03-21 | 382901 | 2023-003 | Significant Deficiency | - | AB |
| 296464 | 2023 | 2024-03-21 | 382900 | 2023-003 | Significant Deficiency | - | AB |
| 296464 | 2023 | 2024-03-21 | 382899 | 2023-003 | Significant Deficiency | - | AB |
| 296464 | 2023 | 2024-03-21 | 382898 | 2023-003 | Significant Deficiency | - | AB |
| 296464 | 2023 | 2024-03-21 | 382897 | 2023-003 | Significant Deficiency | - | AB |
| 296464 | 2023 | 2024-03-21 | 382896 | 2023-003 | Significant Deficiency | - | AB |
| 296464 | 2023 | 2024-03-21 | 382895 | 2023-002 | Significant Deficiency | - | N |
| 296464 | 2023 | 2024-03-21 | 382894 | 2023-002 | Significant Deficiency | - | N |
| 296464 | 2023 | 2024-03-21 | 382893 | 2023-002 | Significant Deficiency | - | N |
| 296464 | 2023 | 2024-03-21 | 382892 | 2023-002 | Significant Deficiency | - | N |
| 296464 | 2023 | 2024-03-21 | 382891 | 2023-002 | Significant Deficiency | - | N |
| 296464 | 2023 | 2024-03-21 | 382890 | 2023-002 | Significant Deficiency | - | N |